Michael Patrick Miller Insider Profile
4 Followers
Michael Patrick Miller, EVP, US Commercial at Jazz Pharmaceuticals, holds 5.94K shares in Rigel (Ticker: RIGL), holds 54.00K shares in Puma Biotechnology (Ticker: PBYI), holds 22.12K shares in Jazz Pharmaceuticals (Ticker: JAZZ).
Michael Patrick Miller Jazz Pharmaceuticals (JAZZ)EVP, US Commercial
Jazz Pharmaceuticals (JAZZ)
EVP, US Commercial
Ranked #74,845 out of 107,514 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-12.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Patrick Miller holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 17, 2022 - Mar 17, 2023
Return:+29.20%
The most profitable trade made by Michael Patrick Miller
Michael Patrick Miller's Trading History
Jazz Pharmaceuticals
Mar 13, 2020
EVP, US Commercial
Uninformative Sell
153.25K
$5.25M
Puma Biotechnology
Nov 13, 2025
Director
Informative Sell
97.20K
$392.58K
Bioxcel Therapeutics
―
Director
―
―
Rigel
May 19, 2026
Director
Uninformative Buy
―
$173.18K
Vivus
Jul 20, 2012
―
Uninformative Sell
759.00K
$1.87K
List of latest transactions for each holding click on a transaction to see Michael Patrick Miller's performance on stock
You May Also Like
Michael Patrick Miller insider profile FAQ
What is the percentage of profitable transactions made by Michael Patrick Miller?
The percentage of profitable transactions made by Michael Patrick Miller is 40%.
What is the average return per transaction made by Michael Patrick Miller?
The average return per transaction made by Michael Patrick Miller is -12.10%.
What stocks does Michael Patrick Miller hold?
Michael Patrick Miller holds: JAZZ, PBYI, BTAI, RIGL, VVUSQ stocks.
What was Michael Patrick Miller’s latest transaction?
Michael Patrick Miller latest transaction was an Uninformative Buy of ―.
What was Michael Patrick Miller's most profitable transaction?
Michael Patrick Miller’s most profitable transaction was an Informative Sell of PBYI stock on March 17, 2022. The return on the trade was 29.20%.
What is Michael Patrick Miller's role in Jazz Pharmaceuticals?
Michael Patrick Miller's role in Jazz Pharmaceuticals is EVP, US Commercial.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.